http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109498681-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1dd683b7977481d83762ec4b8e23281
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-484
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
filingDate 2019-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_229eedf576ff0750ab92e52aa89c96c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a8271e4119735b3230c750fcc4110e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_561982c1b9232543e5fa2b0bf75bab2b
publicationDate 2019-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109498681-A
titleOfInvention A kind of compound licorice tablet and preparation method thereof
abstract The invention discloses a compound licorice tablet and a preparation method thereof. According to the prescription amount, the formula of each compound licorice tablet comprises 112.5 mg of licorice extract powder, 4 mg of poppy fruit extract powder, 2 mg of star anise oil, 2 mg of camphor, 2 mg of sodium benzoate, 2 to 50 mg of cyclodextrin derivatives with an average particle size of 1 to 50 μm, 2 to 50 mg of magnesium oxide, 0 to 100 mg of calcium hydrogen phosphate, 0 to 100 mg of starch, 0 to 20 mg of micropowder silica gel, and 0 to 50 mg of talc ; According to the prescription amount, the core of each compound licorice tablet is 126.5-400 mg in total. The invention adopts the inclusion technology of micropowder cyclodextrin derivatives, and the volatile molecules such as camphor and star anise oil in the compound licorice tablet are included in the inclusion compound molecules, so as to increase the adsorption and fixation effect on the volatile matter, so that the volatile matter is volatile. It is not easy to volatilize and greatly increases the content of volatiles.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114010610-A
priorityDate 2019-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415712230
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14792
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426208976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637563
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID13429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14049689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453808416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID49827
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547150
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID13429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546685
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3469
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID49827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448897384
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24404

Total number of triples: 59.